Skip to main content
Clinical Trials/NCT05415566
NCT05415566
Completed
N/A

The Effect of Therapeutic Play Applied by Using Toy Nebulizer and Toy Mask on Child's Fear and Anxiety Level

Ege University1 site in 1 country84 target enrollmentFebruary 8, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Therapeutic Play
Sponsor
Ege University
Enrollment
84
Locations
1
Primary Endpoint
Reducing the child's fear
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In this study, it was aimed to examine the effect of therapeutic play applied with a toy nebulizer and toy mask before inhaler treatment on children's fear and anxiety.

It is the hypothesis of the study that the therapeutic play applied by using a toy mask and a toy nebulizer before inhaler treatment in children will reduce the child's fear and anxiety.

Detailed Description

Acute diseases constitute the majority of applications made to pediatric emergency services. Inhaled drugs are frequently used in the treatment of childhood acute respiratory system diseases. Nebulizers are the preferred method of administering inhaled drugs. Medical procedures are one of the biggest fears of children, making it difficult to use nebulizers correctly and effectively. The negative reaction of the child to the mask and nebulizer during inhaler treatment causes incorrect inhalation patterns, reducing the safety and effectiveness of the treatment. This causes difficulties in relieving symptoms, increased hospital admission and hospitalization time, more treatment costs, and even negative consequences such as increased morbidity. Reducing the fear and anxiety seen in children due to the hospital environment and illness is important in terms of children's acceptance of the treatment process. One of the methods used for this purpose is therapeutic play. Pediatric nurses should fulfill their nursing roles and responsibilities by including therapeutic play in their care processes.

Registry
clinicaltrials.gov
Start Date
February 8, 2021
End Date
June 3, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ayşe Kahraman

associate professor

Ege University

Eligibility Criteria

Inclusion Criteria

  • Parent and child volunteering to participate in the study,
  • The child is between the ages of 3-8,
  • Being admitted due to respiratory system disease,
  • Inhaler treatment with a nebulizer will be applied.

Exclusion Criteria

  • Parent and child not voluntarily participating in the study,
  • Intravenous, intramuscular or any other treatment request,
  • The child has any genetic, congenital, chronic or metabolic disease,
  • The child has vision, hearing and speech problems,
  • The child's vital signs are unstable (no fever, tachypnea, etc.) and the need for any emergency intervention.

Outcomes

Primary Outcomes

Reducing the child's fear

Time Frame: during inhaler treatment

Reducing the child's fear during inhaler treatment

Reducing the child's anxiety

Time Frame: during inhaler treatment

Reducing the child's anxiety during inhaler treatment

Secondary Outcomes

  • Reducing the "Child Anxiety Scale-Stateness" score(shortly after inhaler treatment)
  • Reducing the "Child Fear Scale" score(shortly after inhaler treatment)

Study Sites (1)

Loading locations...

Similar Trials